For example, GE11 peptide-modified EVs deliver let-7a miRNA to EGFR-expressing xenograft breast tumors, inhibiting the expression of HMGA2 mRNA and thus the tumor development in vivo (Ohno et al., 2013). Here, EGFR is linked to neoplasm.